BTAVF:OTC-BATM Advanced Communications Ltd (USD)

COMMON STOCK | Medical Instruments & Supplies | OTC

Last Closing Price

USD 0.48

Change

0.00 (0.00)%

Market Cap

USD 0.21B

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


BTAVF Stock Forecast & Price:
Based on the BATM Advanced Communications Ltd stock forecasts from 0 analysts, the average analyst target price for BATM Advanced Communications Ltd is not available over the next 12 months. BATM Advanced Communications Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BATM Advanced Communications Ltd is Slightly Bullish , which is based on 2 positive signals and 1 negative signals. At the last closing, BATM Advanced Communications Ltd’s stock price was USD 0.48. BATM Advanced Communications Ltd’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -56.45% over the last year.

No recent analyst target price found for BATM Advanced Communications Ltd
No recent average analyst rating found for BATM Advanced Communications Ltd

About BATM Advanced Communications Ltd (BTAVF:OTC)

BATM Advanced Communications Ltd., together with its subsidiaries, provides real-time technologies for networking solutions and bio-medical systems in Israel, the United States, and Europe. It operates in Networking and Cyber, and Bio-Medical divisions. The Networking and Cyber d ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-08-09 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ESLOF EssilorLuxottica Société ano..

-1.55 (-0.96%)

USD74.30B 40.55 14.61
ESLOY Essilor International SA

-0.85 (-1.03%)

USD73.17B 40.79 14.61
HOCPF HOYA Corporation

N/A

USD40.04B 32.43 0.14
HOCPY Hoya Corp

-0.98 (-0.91%)

USD39.69B 32.24 0.14
SDMHF Sartorius Stedim Biotech S.A

N/A

USD36.49B 50.43 35.30
RSMDF Resmed Inc DRC

N/A

USD35.37B 45.28 30.61
SUVPF Sartorius Aktiengesellschaft

N/A

USD28.21B 48.27 25.25
SARTF Sartorius Aktiengesellschaft

-27.38 (-6.85%)

USD28.21B 55.17 25.25
OCPNF Olympus Corporation

+0.22 (+1.09%)

USD26.91B 31.41 0.12
OCPNY Olympus Corp

-0.41 (-1.93%)

USD26.57B 31.48 0.12

ETFs Containing BTAVF

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Instruments & Supplies)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -53.04% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -53.04% N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain -56.45% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -56.45% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 56.74% 73% C 76% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 56.74% 73% C 75% C
Risk Return Profile  
Volatility (Standard Deviation) 126.36% 30% F 29% F
Risk Adjusted Return 44.90% 52% F 75% C
Market Capitalization 0.21B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Instruments & Supplies)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 14.97 N/A N/A N/A N/A
Price/Book Ratio 1.66 N/A N/A N/A N/A
Price / Cash Flow Ratio 37.72 N/A N/A N/A N/A
EV/EBITDA 4.27 N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 12.15% N/A N/A N/A N/A
Return on Invested Capital 11.61% N/A N/A N/A N/A
Return on Assets 3.61% N/A N/A N/A N/A
Debt to Equity Ratio 1.06% N/A N/A N/A N/A
Technical Ratios  
Dividend Yield 2.09% N/A N/A N/A N/A
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.33 N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.